ATE384797T1 - Streptococcus pyogenes virulenz gene und proteine und ihre verwendungen - Google Patents

Streptococcus pyogenes virulenz gene und proteine und ihre verwendungen

Info

Publication number
ATE384797T1
ATE384797T1 AT00987575T AT00987575T ATE384797T1 AT E384797 T1 ATE384797 T1 AT E384797T1 AT 00987575 T AT00987575 T AT 00987575T AT 00987575 T AT00987575 T AT 00987575T AT E384797 T1 ATE384797 T1 AT E384797T1
Authority
AT
Austria
Prior art keywords
streptococcus pyogenes
proteins
genes
virulence genes
virulence
Prior art date
Application number
AT00987575T
Other languages
English (en)
Inventor
Enda Elizabeth Clarke
Liqing Zhou
Jacqueline Elizabeth Shea
Robert Graham Feldman
David William Holden
Original Assignee
Vmax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930469.3A external-priority patent/GB9930469D0/en
Priority claimed from GBGB9930466.9A external-priority patent/GB9930466D0/en
Priority claimed from GBGB9930476.8A external-priority patent/GB9930476D0/en
Priority claimed from GBGB9930467.7A external-priority patent/GB9930467D0/en
Priority claimed from GBGB9930472.7A external-priority patent/GB9930472D0/en
Priority claimed from GBGB9930474.3A external-priority patent/GB9930474D0/en
Priority claimed from GBGB9930471.9A external-priority patent/GB9930471D0/en
Priority claimed from GBGB9930463.6A external-priority patent/GB9930463D0/en
Priority claimed from GBGB9930464.4A external-priority patent/GB9930464D0/en
Priority claimed from GBGB9930462.8A external-priority patent/GB9930462D0/en
Priority claimed from GBGB9930473.5A external-priority patent/GB9930473D0/en
Priority claimed from GBGB9930475.0A external-priority patent/GB9930475D0/en
Priority claimed from GB0003735A external-priority patent/GB0003735D0/en
Priority claimed from GB0003731A external-priority patent/GB0003731D0/en
Priority claimed from GB0003725A external-priority patent/GB0003725D0/en
Priority claimed from GB0003736A external-priority patent/GB0003736D0/en
Priority claimed from GB0003727A external-priority patent/GB0003727D0/en
Priority claimed from GB0003733A external-priority patent/GB0003733D0/en
Priority claimed from GB0003729A external-priority patent/GB0003729D0/en
Priority claimed from GB0003730A external-priority patent/GB0003730D0/en
Priority claimed from GB0003726A external-priority patent/GB0003726D0/en
Priority claimed from GB0003728A external-priority patent/GB0003728D0/en
Priority claimed from GB0003732A external-priority patent/GB0003732D0/en
Priority claimed from GB0010585A external-priority patent/GB0010585D0/en
Priority claimed from GB0010587A external-priority patent/GB0010587D0/en
Application filed by Vmax Ltd filed Critical Vmax Ltd
Publication of ATE384797T1 publication Critical patent/ATE384797T1/de
Application granted granted Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00987575T 1999-12-23 2000-12-22 Streptococcus pyogenes virulenz gene und proteine und ihre verwendungen ATE384797T1 (de)

Applications Claiming Priority (25)

Application Number Priority Date Filing Date Title
GBGB9930467.7A GB9930467D0 (en) 1999-12-23 1999-12-23 Virulence gene and protein,and their use
GBGB9930472.7A GB9930472D0 (en) 1999-12-23 1999-12-23 Virulence gene and protein,and their use
GBGB9930474.3A GB9930474D0 (en) 1999-12-23 1999-12-23 Virulence gene and protein, and their use
GBGB9930471.9A GB9930471D0 (en) 1999-12-23 1999-12-23 Virulence gene and protein,and their use
GBGB9930463.6A GB9930463D0 (en) 1999-12-23 1999-12-23 Virulence gene and protein and their use
GBGB9930464.4A GB9930464D0 (en) 1999-12-23 1999-12-23 Virullence gene and protein and their use
GBGB9930462.8A GB9930462D0 (en) 1999-12-23 1999-12-23 Virulence gene and protein and their use
GBGB9930473.5A GB9930473D0 (en) 1999-12-23 1999-12-23 Virulence gene and protein, and their use
GBGB9930475.0A GB9930475D0 (en) 1999-12-23 1999-12-23 Virulence gene and protein,and their use
GBGB9930466.9A GB9930466D0 (en) 1999-12-23 1999-12-23 Virulence gene and protein,and their use
GBGB9930476.8A GB9930476D0 (en) 1999-12-23 1999-12-23 Virulence gene and protein,and their use
GBGB9930469.3A GB9930469D0 (en) 1999-12-23 1999-12-23 Virulence gene and protein,and their use
GB0003736A GB0003736D0 (en) 2000-02-17 2000-02-17 Virulence gene and protein, an their use
GB0003727A GB0003727D0 (en) 2000-02-17 2000-02-17 Virulence gene and protein and their use
GB0003733A GB0003733D0 (en) 2000-02-17 2000-02-17 Virulence gene and protein, and their use
GB0003729A GB0003729D0 (en) 2000-02-17 2000-02-17 Virulene gene and protein, and their use
GB0003731A GB0003731D0 (en) 2000-02-17 2000-02-17 Virulence gene and protein, and their use
GB0003726A GB0003726D0 (en) 2000-02-17 2000-02-17 Virulence gene and protein and their use
GB0003728A GB0003728D0 (en) 2000-02-17 2000-02-17 Virulence gene and protein, and their use
GB0003732A GB0003732D0 (en) 2000-02-17 2000-02-17 Virulence gene and protein, and their use
GB0003735A GB0003735D0 (en) 2000-02-17 2000-02-17 Virulence gene and protein, and their use
GB0003730A GB0003730D0 (en) 2000-02-17 2000-02-17 Virulence gene and protein, and their use
GB0003725A GB0003725D0 (en) 2000-02-17 2000-02-17 Virulence gene and protein and their use
GB0010585A GB0010585D0 (en) 2000-05-02 2000-05-02 Virulence gene and protein, and their use
GB0010587A GB0010587D0 (en) 2000-05-02 2000-05-02 Virulence gene and protein, and their use

Publications (1)

Publication Number Publication Date
ATE384797T1 true ATE384797T1 (de) 2008-02-15

Family

ID=27586758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00987575T ATE384797T1 (de) 1999-12-23 2000-12-22 Streptococcus pyogenes virulenz gene und proteine und ihre verwendungen

Country Status (12)

Country Link
US (2) US6951732B2 (de)
EP (2) EP1905834A3 (de)
JP (1) JP2003520034A (de)
KR (1) KR20020073150A (de)
AT (1) ATE384797T1 (de)
AU (1) AU775385B2 (de)
CA (1) CA2397710A1 (de)
HK (1) HK1048134B (de)
HU (1) HUP0203880A2 (de)
NO (1) NO20023006L (de)
NZ (1) NZ519669A (de)
WO (1) WO2001048208A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100551104B1 (ko) * 1994-12-09 2006-02-09 임페리얼 컬리지 이노베이션스 리미티드 유전자의 동정
DE69939264D1 (de) * 1998-09-04 2008-09-18 Emergent Product Dev Uk Ltd Attenuierte salmonella spi2 mutante als antigen-träger
GB9910812D0 (en) * 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
WO2006048753A2 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
WO2006048757A2 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
GB2428006A (en) * 2005-07-07 2007-01-17 Jevgenis Morov AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria
US8703153B2 (en) 2008-06-16 2014-04-22 Prokarium Ltd. Salmonella vectored vaccines against Chlamydia and methods of use
EP2135877A1 (de) 2008-06-19 2009-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Streptococcus anginosus-/Streptococcus constellatus-Marker (Moac) und Verwendungen davon
RU2580299C2 (ru) * 2009-06-29 2016-04-10 Дженосеа Биосайенсиз, Инк. Вакцины и композиции, направленные против streptococcus pneumoniae
WO2012100233A1 (en) 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9503495L (sv) * 1995-10-09 1997-04-10 Actinova Ltd Nytt protein
US6737248B2 (en) * 1996-01-05 2004-05-18 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences
US6346392B1 (en) * 1996-11-27 2002-02-12 Smithkline Beecham Corporation Polynucleotides encoding a novel glutamine transport ATP-binding protein
JP4469026B2 (ja) * 1996-10-31 2010-05-26 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅの抗原およびワクチン
CA2881568C (en) * 2000-10-27 2019-09-24 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from streptococcus groups a & b

Also Published As

Publication number Publication date
EP1240332B1 (de) 2008-01-23
NO20023006D0 (no) 2002-06-21
US20030072769A1 (en) 2003-04-17
EP1905834A3 (de) 2008-07-23
JP2003520034A (ja) 2003-07-02
KR20020073150A (ko) 2002-09-19
WO2001048208A3 (en) 2001-12-20
NO20023006L (no) 2002-06-21
CA2397710A1 (en) 2001-07-05
HUP0203880A2 (hu) 2003-03-28
EP1905834A2 (de) 2008-04-02
US6951732B2 (en) 2005-10-04
WO2001048208A2 (en) 2001-07-05
NZ519669A (en) 2004-03-26
HK1048134A1 (en) 2003-03-21
AU2382301A (en) 2001-07-09
US20050232942A1 (en) 2005-10-20
AU775385B2 (en) 2004-07-29
HK1048134B (en) 2008-09-05
EP1240332A2 (de) 2002-09-18

Similar Documents

Publication Publication Date Title
DE60132084D1 (de) Virulenz gene, proteine, und ihre verwendung
DK1870417T3 (da) Peptidacceptor-ligeringsmetoder
DK2333097T3 (da) Enzymer med alpha-amylase-aktivitet og fremgangsmåder til anvendelse deraf
ATE384797T1 (de) Streptococcus pyogenes virulenz gene und proteine und ihre verwendungen
DE60031395D1 (de) Mikrobielle beta-glukuronidase gene, genprodukte und deren verwendungen
ATE353366T1 (de) Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
DE60139544D1 (de) Veränderte, fluoreszierende proteine
DK1154791T3 (da) Neisseria-vaccinesammensætninger og fremgangsmåder
DE69937965D1 (de) Virulenzgene und deren proteine und verwendungen
FR2793257B1 (fr) Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
WO2003008545A3 (en) Antisense modulation of glioma-associated oncogene-2 expression
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
NO20013102D0 (no) Gener, proteiner og deres anvendelse
WO2001032697A3 (en) Virulence genes and proteins from brucella melitensis, and their use
WO2003000930A3 (en) Nucleotide sequences involved in plant disease resistance
DE60126765D1 (de) Virulenz gene, proteine, und ihre verwendung
ATE466023T1 (de) Mannose-spezifische adhesinen und deren vervendung
ATE403716T1 (de) Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungen
WO2002016612A3 (en) Genes and proteins, and their uses
WO2004057018A3 (en) Pseudomonas aeruginosa and klebsiella virulence genes, proteins, and their use
FR2813606B1 (fr) Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
DE60037908D1 (de) Streptococcus pyogenes virulenz gene und proteine und ihre verwendungen
ATE221895T1 (de) Chimäre oligonucleotide und ihre verwendung
WO2001011063A3 (de) Kombinationsvektoren für den gentransfer, verfahren zu ihrer herstellung und ihre verwendung
WO2002077020A3 (en) Virulence genes in h. influenzae

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties